| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |